Laboratory Corporation of America Holdings

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 18 Jan 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

1.5 Fte (6)

Lobbyists with EP accreditation

1

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Laboratory Corporation of America Holdings   (Labcorp)

    EU Transparency Register

    878238423039-24 First registered on 17 Aug 2016

    Goals / Remit

    Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world.

    Main EU files targeted

    All EU initiatives, policies and legislative files related to:
    Scientific Research Collaboration programs
    Clinical Trial Patient Engagement
    Real World Data
    Mobile and Digital Health initiatives
    Diagnostics
    Data Protection and Privacy
    Artificial Intelligence
    Animal Research
    ESG
    Crop Protection and Chemical

    Address

    Head Office
    531 South Spring Street
    Burlington 27215
    UNITED STATES
    EU Office
    Zandvoortstraat 2
    Mechelen
    BELGIUM

    Website

  • People

    Total lobbyists declared

    6

    Employment timeLobbyists
    25%6

    Lobbyists (Full time equivalent)

    1.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 29 Apr 2024

    Name Start date End Date
    Sabine Schneider Nash 06 Mar 2024 05 Mar 2025
    Ms Sabine Schneider Nash 06 Mar 2024 15 Apr 2024
    Ms Sabine Schneider Nash 05 Nov 2019 31 Oct 2020
    Ms Sabine Schneider Nash 28 Oct 2016 28 Oct 2017

    Complementary Information

    1 Person involved from Labcorp, 1 through the law firm, 4 through the Public Affairs firm

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    - European Federation of the Pharmaceutical Industry and Associations (EFPIA), Partner in Research
    - Association of the British Pharmaceutical Industry (ABPI), Research Affiliate
    - European Animal Research Association (EARA)
    - Association of Clinical Research Associations (ACRO)
    - Medtech and Pharma (MPP)
    - European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    Our Public Affairs Firm, FTI Consulting, focuses mainly on monitoring legislative developments and reporting

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Labcorp focuses on monitoring legislation, policies and directives and working through Associations such as EFPIA, ACRO, EARA, EUCOPE and MPP to give guidance on areas impacted.

    Other activities

    • LabCorp started in February 2016 to implement a Public Affairs programme in Europe.
    • LabCorp is a Partner in Research at EFPIA and has access to the EU funded Innovative Medicine Initiative (IMI).

    Ad-hoc participation in European Commission workshops and stakeholder meetings

  • Meetings

    Meetings

    None declared

Download this datacard